Pluripotency transcription factors and cancer stem cells: small genes make a big difference
- PMID: 23419197
- PMCID: PMC3845564
- DOI: 10.5732/cjc.012.10282
Pluripotency transcription factors and cancer stem cells: small genes make a big difference
Abstract
Cancer stem cells (CSCs) are thought to drive uncontrolled tumor growth, and the existence of CSCs has recently been proven by direct experimental evidence, including tracing cell lineages within a growing tumor. However, CSCs must be analyzed in additional cancer types. Cancer stem cell-like cells (CSCLCs) are a good alternative system for the study of CSCs, which hold great promise for clinical applications. OCT4, NANOG, and SOX2 are three basic transcription factors that are expressed in both CSCLCs and embryonic stem cells (ESCs). These transcription factors play critical roles in maintaining the pluripotence and self-renewal characteristics of CSCLCs and ESCs. In this review, we discuss the aberrant expression, isoforms, and pseudogenes of OCT4, NANOG, and SOX2 in the CSCLC niche, which contribute to the major differences between CSCLCs and ESCs. We also highlight an anticancer therapy that involves killing specific cancer cells directly by repressing the expression of OCT4, NANOG, or SOX2. Importantly, OCT4, NANOG, and SOX2 provide great promise for clinical applications because reducing their expression or blocking the pathways in which they function may inhibit tumor growth and turn-off the cancer "switch." In the future, a clear understanding of transcription factor regulation will be essential for elucidating the roles of OCT4, NANOG, and SOX2 in tumorigenesis, as well as exploring their use for diagnostic and therapeutic purposes.
Similar articles
-
Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.J Biol Chem. 2012 Sep 21;287(39):32800-24. doi: 10.1074/jbc.M111.308528. Epub 2012 Jul 30. J Biol Chem. 2012. PMID: 22847005 Free PMC article.
-
Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.Histopathology. 2011 Oct;59(4):763-75. doi: 10.1111/j.1365-2559.2011.03993.x. Histopathology. 2011. PMID: 22014056
-
Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).Tumour Biol. 2017 Apr;39(4):1010428317692253. doi: 10.1177/1010428317692253. Tumour Biol. 2017. PMID: 28378634 Review.
-
Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells.Cell Stem Cell. 2012 Apr 6;10(4):440-54. doi: 10.1016/j.stem.2012.02.016. Cell Stem Cell. 2012. PMID: 22482508
-
Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.Stem Cells Dev. 2009 Sep;18(7):1093-108. doi: 10.1089/scd.2009.0113. Stem Cells Dev. 2009. PMID: 19480567 Free PMC article. Review.
Cited by
-
Profiling of Gene Expression Associated with Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells.Malays J Med Sci. 2019 Sep;26(5):38-52. doi: 10.21315/mjms2019.26.5.4. Epub 2019 Nov 4. Malays J Med Sci. 2019. PMID: 31728117 Free PMC article.
-
β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling.Am J Cancer Res. 2022 Apr 15;12(4):1535-1555. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530288 Free PMC article.
-
Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.Sci Rep. 2020 May 12;10(1):7885. doi: 10.1038/s41598-020-64664-3. Sci Rep. 2020. PMID: 32398775 Free PMC article.
-
Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.Cell Rep. 2020 Feb 4;30(5):1478-1490.e6. doi: 10.1016/j.celrep.2019.11.040. Cell Rep. 2020. PMID: 32023463 Free PMC article.
-
Development of a real-time imaging system for hypoxic cell apoptosis.Mol Ther Methods Clin Dev. 2016 Mar 2;5:16009. doi: 10.1038/mtm.2016.9. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 26966700 Free PMC article.
References
-
- Clarke M, Dick J, Dirks P, et al. Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344. - PubMed
-
- Schepers AG, Snippert HJ, Stange DE, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science. 2012;337:730–735. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials